Dosage form(s):
The acceptable pharmaceutical dosage forms include, but are not limited to, chewables (e.g. gummies, tablets), caplets, capsules, strips, lozenges, powders or liquids where the dose is measured in drops, teaspoons or tablespoons. This monograph is not intended to include foods or food-like dosage forms such as bars, chewing gums or beverages.
Use(s) or Purpose(s):
Statement(s) to the effect of:
< Used in Herbal Medicine to help relieve premenstrual symptoms (WHO 2009; Bradley 2006; Wichtl 2004; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000) . See Appendix 1 for examples of appropriate dosage preparations, frequencies of use and directions for use, according to cited references. The purpose of Appendix 1 is to provide guidance to industry.
Duration(s) of use:
Use for a minimum of 3 month to see beneficial effects (Bradley 2006; ESCOP 2003; Hoffmann 2003) .
Risk information:
Caution(s) and warning(s):
< Consult a health care practitioner if symptoms persist or worsen. < Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006 ).
Contraindication(s):
No statement required.
Known adverse reaction(s):
Non-medicinal ingredients:
Must be chosen from the current NHPD Natural Health Products Ingredients Database and must meet the limitations outlined in the database.
Specifications:
< The finished product must comply with the minimum specifications outlined in the current NHPD Compendium of
Monographs. <
The medicinal ingredient may comply with the specifications outlined in the pharmacopoeial monographs listed in Table 1 below. Tablet: 500 mg dried fruit, 1-2 tablets per day (Mills and Bone 2000) Dried extract: Preparations equivalent to 40-240 mg of dried fruits, per day (50-70% ethanol) (Bradley 2006) 
